Amedica Announces FDA Clearance Of Expanded Valeo II Lateral Lumbar Sizes

(RTTNews) - Amedica Corp. (AMDA) announced the U.S. Food and Drug Administration clearance of expanded Valeo II Lateral Lumbar sizes. The additional sizes of the Valeo II LL interbody fusion device will be commercially available August 29, 2016.

In the pre-market, AMDA is trading at $1.29, up $0.13 or 11.21 percent.

The Valeo II LL interbody fusion device is made entirely of Amedica's proprietary medical grade silicon nitride ceramic -- an ideal material for fusion, due to its inherent osteoconductivity, anti-infective properties, bone-like imaging (artifact-free & radiotranslucent), and exceptional strength. The system includes second generation instrumentation to improve patient safety and surgeon ease of use.

The Valeo II LL is indicated for intervertebral body fusion of the spine in skeletally mature patients and is designed for use with autograft to facilitate fusion.